Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati

📆 06/10/2023 05.19.00

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

(Bloomberg) -- French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people familiar with the matter.Most Read from BloombergAlmost Anyone Can Become the House Speaker, Except Donald TrumpOzempic Is Making People Buy Less Food, Walmart SaysOnly an Equities Crash Can Rescue the Bond Market, Barclays SaysThe Moral Case for No Longer Engaging With Elon Musk’s XIt's Done. The Future Is Battery-Powered Electric CarsMirati’s

📆 06/10/2023 05.19.00
📰 YahooFinanceCA

⏱ Reading Time:
14 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 63%

-- French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people familiar with the matter.It's Done. The Future Is Battery-Powered Electric Cars

Deliberations are ongoing and there’s no certainty they will result in an agreement. Mirati could also attract interest from other suitors, the people said. A sale would give Mirati further resources to help it commercialize the treatment and fund further studies.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Tulis Komentar

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

$Sanofi to explore acquisition of cancer drugmaker Mirati\u002D Bloomberg News$ Sanofi to explore acquisition of cancer drugmaker Mirati\u002D Bloomberg NewsExplore stories from Atlantic Canada.
Baca lebih lajut »